This Series on “Thrombotic Thrombocytopenic Purpura” is edited by Dr. X. Long Zheng from University of Kansas Medical Center, Kansas City, KS, USA
Editorial on Thrombotic Thrombocytopenic Purpura
Introductory comments about the special series of thrombotic microangiopathy
Review Article on Thrombotic Thrombocytopenic Purpura
The history of thrombotic thrombocytopenic purpura research: a narrative review
Congenital thrombotic thrombocytopenic purpura: genetics and emerging therapies
Immune thrombotic thrombocytopenic purpura: pathogenesis and novel therapies: a narrative review
A narrative review of clinical biomarkers predicting outcome of immune-mediated thrombotic thrombocytopenic purpura
Atypical hemolytic uremic syndrome: genetically-based insights into pathogenesis through an analysis of the complement regulator CD46
A narrative review of transplant-associated thrombotic microangiopathy: pathogenesis and novel therapies
Animal models for thrombotic thrombocytopenic purpura: a narrative review
Disclosure:
The series “Thrombotic Thrombocytopenic Purpura” was commissioned by the editorial office, Annals of Blood without any sponsorship or funding. Dr. X. Long Zheng served as the unpaid Guest Editor for the series.